Belluscura (FRA:9VQ) Long-Term Debt : €0.00 Mil (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Belluscura Long-Term Debt?

Belluscura's Long-Term Debt for the quarter that ended in Jun. 2023 was €0.00 Mil.

Belluscura's annual Long-Term Debt increased from Dec. 2020 (€0.01 Mil) to Dec. 2021 (€0.02 Mil) but then declined from Dec. 2021 (€0.02 Mil) to Dec. 2022 (€0.00 Mil).

Belluscura Long-Term Debt Historical Data

The historical data trend for Belluscura's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belluscura Long-Term Debt Chart

Belluscura Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Debt

0.01

0.02

Belluscura Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Long-Term Debt	Get a 7-Day Free Trial				-	0.02	-	-	-

Belluscura (FRA:9VQ) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Belluscura Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Belluscura's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Belluscura (FRA:9VQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Belluscura PLC (FRA:9VQ) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BELL:UK

Address

15 Fetter Lane, Holborn, London, GBR, EC4A 1BW

Website

https://www.belluscura.com

Belluscura PLC is a medical device company. Its first product, the X-PLOR, is a lightweight FDA-cleared portable oxygen concentrator designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The X-PLO2R weighs less than 1.5kg (3.25 lbs) and it is the first modular portable oxygen concentrator it will generate more oxygen by weight than any other FDA-cleared POC in its class. It either owns or exclusively licenses a total of 26 patents and applications relating to oxygen enrichment devices and treatments.

Belluscura (FRA:9VQ) Headlines

No Headlines